TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N105 Class: COMMON STOCK

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019
Shares 364,785 Value ($000) $175 Avg Close — Range —
Q1 2019
Shares 378,308 Value ($000) $507 Avg Close — Range —
Q4 2018
Shares 394,141 Value ($000) $445 Avg Close — Range —
Q3 2018
Shares 284,351 Value ($000) $785 Avg Close — Range —
Q2 2018
Shares 192,871 Value ($000) $689 Avg Close — Range —
Q1 2018
Shares 367,901 Value ($000) $1,130 Avg Close — Range —
Q2 2017
Shares 652 Value ($000) $5 Avg Close — Range —
Q1 2017
Shares 17,269 Value ($000) $159 Avg Close — Range —
Q4 2016
Shares 16,882 Value ($000) $68 Avg Close — Range —
Q3 2016
Shares 6,193 Value ($000) $24 Avg Close — Range —
Q2 2016
Shares 406 Value ($000) $2 Avg Close — Range —
Q1 2016
Shares 10,500 Value ($000) $48 Avg Close — Range —
Q4 2015
Shares 31,435 Value ($000) $316 Avg Close — Range —
Q3 2015
Shares 40,411 Value ($000) $302 Avg Close — Range —
Q2 2015
Shares 38,567 Value ($000) $1,830 Avg Close — Range —
Q1 2015
Shares 40,253 Value ($000) $1,475 Avg Close — Range —
Q4 2014
Shares 9,038 Value ($000) $359 Avg Close — Range —